Coiled-coil domain of PML is essential for the aberrant dynamics of PML-RARα, resulting in sequestration and decreased mobility of SMRT

Biochemical and Biophysical Research Communications

Volumn 365, Issue 2, 2008, Pages 258-265

  Huang, Ying ^a   Qiu, Jihui ^c   Chen, Guoqiang ^a   Dong, Shuo ^a,b,c  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CBP; Coiled coil domain; FRAP; PML RAR ; SMRT

Indexed keywords

BINDING PROTEIN; CYCLIC AMP; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; THYROID HORMONE RECEPTOR;

ARTICLE; CELL LEVEL; CELLULAR DISTRIBUTION; DYNAMICS; FLUORESCENCE MICROSCOPY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMAN; HUMAN CELL; INTROSPECTION; LEUKEMOGENESIS; MOLECULAR MECHANICS; MOLECULE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; PROTEIN IMMOBILIZATION; SUMOYLATION; WILD TYPE;

CELL LINE; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; KIDNEY; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 36248931601     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.184     Document Type: Article

References (18)

1. Zelent A., Guidez F., Melnick A., Waxman S., and Licht J.D. Translocations of the RARalpha gene in acute promyelocytic leukemia. Oncogene 20 (2001) 7186-7203
2. Melnick A., and Licht J.D. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93 (1999) 3167-3215
3. Kamashev D., Vitoux D., and De The H. PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation. J. Exp. Med. 199 (2004) 1163-1174
4. Kwok C., Zeisig B.B., Dong S., and So C.W. Forced homo-oligomerization of RARalpha leads to transformation of primary hematopoietic cells. Cancer Cell 9 (2006) 95-108
5. Duprez E., Saurin A.J., Desterro J.M., Lallemand-Breitenbach V., Howe K., Boddy M.N., Solomon E., de The H., Hay R.T., and Freemont P.S. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J. Cell Sci. 112 Pt 3 (1999) 381-393
6. Zhong S., Muller S., Ronchetti S., Freemont P.S., Dejean A., and Pandolfi P.P. Role of SUMO-1-modified PML in nuclear body formation. Blood 95 (2000) 2748-2752
7. Zhu J., Zhou J., Peres L., Riaucoux F., Honore N., Kogan S., and de The H. A sumoylation site in PML/RARA is essential for leukemic transformation. Cancer Cell 7 (2005) 143-153
8. Lallemand-Breitenbach V., Zhu J., Puvion F., Koken M., Honore N., Doubeikovsky A., Duprez E., Pandolfi P.P., Puvion E., Freemont P., and de The H. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193 (2001) 1361-1371
9. Qiu J., Wong J., Tweardy D.J., and Dong S. Decreased intranuclear mobility of acute myeloid leukemia 1-containing fusion proteins is accompanied by reduced mobility and compartmentalization of core binding factor beta. Oncogene 25 (2006) 3982-3993
10. Dong S., Stenoien D.L., Qiu J., Mancini M.A., and Tweardy D.J. Reduced intranuclear mobility of APL fusion proteins accompanies their mislocalization and results in sequestration and decreased mobility of retinoid X receptor alpha. Mol. Cell Biol. 24 (2004) 4465-4475
11. Qiu J., Huang Y., Chen G., Chen Z., Tweardy D.J., and Dong S. Aberrant chromatin remodeling by retinoic acid receptor {alpha} fusion proteins assessed at the single-cell level. Mol. Biol. Cell 18 (2007) 3941-3951
12. Stenoien D.L., Nye A.C., Mancini M.G., Patel K., Dutertre M., O'Malley B.W., Smith C.L., Belmont A.S., and Mancini M.A. Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor alpha-coactivator complexes in living cells. Mol. Cell Biol. 21 (2001) 4404-4412
13. Kamitani T., Kito K., Nguyen H.P., Wada H., Fukuda-Kamitani T., and Yeh E.T. Identification of three major sentrinization sites in PML. J. Biol. Chem. 273 (1998) 26675-26682
14. Kim Y.E., Kim D.Y., Lee J.M., Kim S.T., Han T.H., and Ahn J.H. Requirement of the coiled-coil domain of PML-RARalpha oncoprotein for localization, sumoylation, and inhibition of monocyte differentiation. Biochem. Biophys. Res. Commun. 330 (2005) 746-754
15. Lin R.J., Nagy L., Inoue S., Shao W., Miller Jr. W.H., and Evans R.M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391 (1998) 811-814
16. Reineke E.L., Liu H., Lam M., Liu Y., and Kao H.Y. Aberrant association of promyelocytic leukemia protein-retinoic acid receptor-{alpha} with coactivators contributes to its ability to regulate gene expression. J. Biol. Chem. 282 (2007) 18584-18596
17. Sternsdorf T., Puccetti E., Jensen K., Hoelzer D., Will H., Ottmann O.G., and Ruthardt M. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol. Cell Biol. 19 (1999) 5170-5178
18. Boisvert F.M., Kruhlak M.J., Box A.K., Hendzel M.J., and Bazett-Jones D.P. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J. Cell Biol. 152 (2001) 1099-1106